Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Teva Pharmaceuticals USA

Teva Pharmaceuticals USA Recalls

All product recalls associated with Teva Pharmaceuticals USA.

Get alerts for this brand

Recall Summary

Total Recalls

266

Past Year

6

Class I (Serious)

7

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 81–100 of 266 recalls

Metoclopramide Injection (Teva) – Chemical Contamination (2021)

Chemical contamination; Unknown brown residue adhering to the inside of one vial.

Class IIModerate

FDAFeb 15, 2021Nationwide• Teva Pharmaceuticals USA

Epoprostenol Sodium (Teva) – sterility risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Leucovorin Calcium (Teva) – sterility risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

1...3 456 7...14

Page 5 of 14Next

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Methylprednisolone Acetate (Teva) – Sterility Risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Methylprednisolone Acetate (Teva) – sterility risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Epoprostenol Sodium (Teva) – sterility risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Epoprostenol Diluent (Teva) – Sterility Risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Vecuronium Bromide (Teva) – Sterility Risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Metoclopramide Injection (Teva) – Sterility Risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Methylprednisolone Acetate (Teva) – sterility risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Methylprednisolone Acetate (Teva) – sterility risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Toposar Etoposide (Teva) – sterility risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Dacarbazine Injection (Teva) – sterility risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Leucovorin Calcium (Teva) – Sterility Risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Methylprednisolone Acetate (Teva) – sterility risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Desmopressin Acetate (Teva) – Sterility Risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Testosterone Gel (Teva) – Superpotent Medication (2020)

Superpotent Drug: High out-of-specification assay results were obtained during stability testing.

FDANov 11, 2020Nationwide• Teva Pharmaceuticals USA

Mesalamine Tablets (Teva) – Dissolution Failure (2020)

Failed Dissolution Specifications: Out-of-specification dissolution results were obtained during stability testing.

Class IIModerate

FDAOct 28, 2020Nationwide• Teva Pharmaceuticals USA

Buprenorphine Transdermal System (Teva) – Stability Specification Failure (2020)

Failed Stability Specifications: Below specification result for buprenorphine release rate.

Class IIModerate

FDASep 4, 2020Nationwide• Teva Pharmaceuticals USA

Cephalexin Oral Suspension 125mg (Teva) – Potency Inconsistency (2020)

CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Class IIModerate

FDAAug 24, 2020Nationwide• Teva Pharmaceuticals USA